Thadhani R - Search Results

1

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Chan KE, Lazarus JM, Thadhani R, Hakim RM. Chan KE, et al. Among authors: thadhani r. J Am Soc Nephrol. 2009 Oct;20(10):2223-33. doi: 10.1681/ASN.2009030319. Epub 2009 Aug 27. J Am Soc Nephrol. 2009. PMID: 19713308 Free PMC article.

2

Adherence barriers to chronic dialysis in the United States.

Chan KE, Thadhani RI, Maddux FW. Chan KE, et al. J Am Soc Nephrol. 2014 Nov;25(11):2642-8. doi: 10.1681/ASN.2013111160. Epub 2014 Apr 24. J Am Soc Nephrol. 2014. PMID: 24762400 Free PMC article.

3

Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW. Chan KE, et al. Among authors: thadhani ri. Circulation. 2015 Mar 17;131(11):972-9. doi: 10.1161/CIRCULATIONAHA.114.014113. Epub 2015 Jan 16. Circulation. 2015. PMID: 25595139 Free PMC article.

4

A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.

Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE. Nigwekar SU, et al. J Am Soc Nephrol. 2016 Nov;27(11):3421-3429. doi: 10.1681/ASN.2015091065. Epub 2016 Apr 14. J Am Soc Nephrol. 2016. PMID: 27080977 Free PMC article.

5

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, Hakim RM. Chan KE, et al. Among authors: thadhani ri. J Am Soc Nephrol. 2012 Sep;23(9):1551-9. doi: 10.1681/ASN.2012010050. Epub 2012 Aug 16. J Am Soc Nephrol. 2012. PMID: 22904350 Free PMC article.

6

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease.

Chan KE, Thadhani RI, Maddux FW. Chan KE, et al. Kidney Int. 2013 Sep;84(3):555-61. doi: 10.1038/ki.2013.152. Epub 2013 May 15. Kidney Int. 2013. PMID: 23677243 Free article.

7

Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R. Teng M, et al. Among authors: thadhani r. J Am Soc Nephrol. 2005 Apr;16(4):1115-25. doi: 10.1681/ASN.2004070573. Epub 2005 Feb 23. J Am Soc Nephrol. 2005. PMID: 15728786

8

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Chan KE, Lazarus JM, Thadhani R, Hakim RM. Chan KE, et al. Among authors: thadhani r. J Am Soc Nephrol. 2009 Apr;20(4):872-81. doi: 10.1681/ASN.2008080824. Epub 2009 Mar 18. J Am Soc Nephrol. 2009. PMID: 19297555 Free PMC article.

9

Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.

Chan KE, Thadhani R, Lazarus JM, Hakim RM. Chan KE, et al. Among authors: thadhani r. Clin J Am Soc Nephrol. 2010 May;5(5):856-66. doi: 10.2215/CJN.07161009. Epub 2010 Mar 25. Clin J Am Soc Nephrol. 2010. PMID: 20338963 Free PMC article.

10

Early outcomes among those initiating chronic dialysis in the United States.

Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM. Chan KE, et al. Among authors: thadhani r. Clin J Am Soc Nephrol. 2011 Nov;6(11):2642-9. doi: 10.2215/CJN.03680411. Epub 2011 Sep 29. Clin J Am Soc Nephrol. 2011. PMID: 21959599 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters